Active GLP-1 Medication Lawsuits
Thousands of patients nationwide have filed lawsuits against Novo Nordisk and Eli Lilly after suffering serious injuries from GLP-1 receptor agonist medications including Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus. The multidistrict litigation (MDL 3094) consolidates federal cases in the Eastern District of Pennsylvania.
Lawsuit Overview & Updates
Do I Qualify for a Lawsuit?
Settlement Amounts & Compensation
Side Effects With Legal Implications
- Mounjaro Chronic Vomiting — When It Crosses the Legal Threshold
- Mounjaro Emergency Surgery From GLP-1 Drug — Legal Options
- Mounjaro Feeding Tube After GLP-1 Drug — Legal Claim Guide
- Mounjaro Gallbladder Pain — Lawsuit Qualifying Symptoms
- Mounjaro Gastroparesis Symptoms — When to Call a Lawyer
- Mounjaro Hospitalized for Side Effects — Lawsuit Guide
- Mounjaro Intestinal Blockage Symptoms — Your Legal Options
- Mounjaro Kidney Damage Signs — When to Take Legal Action
- Mounjaro Malnutrition From GLP-1 Drugs — Lawsuit Options
- Mounjaro Pancreatitis Signs That May Make You Lawsuit Eligible
- Mounjaro Stomach Pain That Could Be Lawsuit-Worthy
- Mounjaro Thyroid Changes After GLP-1 Use — Legal Guide
How to File & What You Need
- Evidence You Need for an Ozempic Lawsuit
- Gastric Emptying Scintigraphy — The Key Test for Your Lawsuit
- How Long Do I Have to File After an Ozempic Injury?
- How to Document Ozempic Side Effects for Your Lawsuit
- How to File an Ozempic Lawsuit — Step-by-Step Guide
- How to Find the Right Ozempic Lawsuit Attorney
- How to Get Your Pharmacy Records for an Ozempic Lawsuit
- Keeping a Symptom Diary for Your Ozempic Lawsuit
FDA Warnings & Drug Safety News
- Clinical Trial Data Novo Nordisk Allegedly Concealed
- European Medicines Agency GLP-1 Review — Global Impact
- FDA Adverse Event Reports (FAERS) — Ozempic Data
- FDA GLP-1 Intestinal Blockage Warning — Safety Communication
- FDA Inspection of Novo Nordisk Manufacturing Facilities
- FDA Mounjaro Gallbladder Warning 2026 — What Changed
- FDA NAION Vision Loss Warning — Semaglutide Safety Alert
- FDA Ozempic Gastroparesis Warning Timeline — Complete History
Lawsuits By State
About This Resource
OzempicLawsuits.net is an independent legal research resource. Our Legal Research Team tracks GLP-1 receptor agonist litigation developments, FDA safety communications, and published court filings to provide accurate, up-to-date information for individuals who may have been harmed by these medications. This site is not a law firm and does not provide legal advice.